Results 21 to 30 of about 19,359,542 (209)
Pediatric Infectious Disease Journal, 2021 Background: Coronavirus disease-2019 (COVID-19) is characterized predominantly by respiratory symptoms and has affected a small subset of children. Multisystem inflammatory syndrome in children (MIS-C) has been reported in children following COVID-19.
Nihal, Akçay +6 more
openaire +3 more sources
Machine learning model performance in identifying patients with PASC (MIS-C or non-MIS-C variants).
, 2023 The table displays several performance metrics for each of the three outcomes (PASC (any), non MIS-C PASC, and MIS-C). Accuracy, F1 score, precision, and recall were all computed at the p = 0.5 threshold.
Levon Utidjian (16814006) +17 more
core +1 more source
Life, 2023 Background: Hyperinflammatory response that resembles Kawasaki disease may develop in children after COVID-19 disease, and it is called multisystem inflammatory syndrome in children.
Davor Petrovic +6 more
doaj +1 more source
Pediatric Rheumatology Online Journal, 2023 Background and objective Evidence for the treatment of multisystem inflammatory syndrome in children (MIS-C) is lacking. Anakinra, which targets IL-1-mediated inflammation, is reserved for refractory cases of MIS-C; however, its use in the treatment of ...
Brian L.P. Dizon +13 more
doaj +1 more source
Guidelines for immunization of children following multisystem inflammatory syndrome in children
Pediatria Polska, 2022 Multisystem inflammatory syndrome in children (MIS-C) is a late complication of SARS-CoV-2 infection, either symptomatic or asymptomatic. The underlying cause is immunological dysregulation, leading to severe inflammatory processes.
Kamila Ludwikowska +7 more
doaj +1 more source
Unraveling the mechanisms of IVIG immunotherapy in MIS-C [PDF]
Cell Reports Medicine, 2021 In The Journal of Clinical Investigation, Zhu et al.1 report that intravenous immunoglobulin (IVIG) targets IL-1β+ neutrophils to exert anti-inflammatory effects in multisystem inflammatory syndrome in children (MIS-C), a post-infectious inflammatory condition associated with COVID-19.
Madhusudan Ganigara +2 more
openaire +3 more sources
Frontiers in Pediatrics, 2023 ObjectiveEstimate the incidence of multisystem inflammatory syndrome (MIS-C) in children (0–15 years), the role of SARS-CoV-2 variants during the first two years of COVID-19 pandemic in Luxembourg; and describe the demographic, biological and clinical ...
C. Ooms +9 more
doaj +1 more source
Children, 2023 This study aimed to investigate the characteristics of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome (KDSS) and to compare the similarities and differences between the two diseases.
Jin Lee +5 more
doaj +1 more source
Critical Care, 2020 Background Multisystem inflammatory syndrome temporally associated with COVID-19 (MIS-C) has been described as a novel and often severe presentation of SARS-CoV-2 infection in children.
Alberto García-Salido +26 more
doaj +1 more source
Is It Stevens–Johnson Syndrome or MIS‐C with Mucocutaneous Involvement? [PDF]
Case Reports in Pediatrics, 2021 Background Severe acute respiratory syndrome coronavirus‐2 (SARS‐COV‐2) can be present in the form of multisystem inflammatory disease in children. Case Presentation A 25‐month‐old boy presented with fever, malaise, diffuse ...
Abdollah Karimi +5 more
openaire +3 more sources